PRPO
NASD Precipio, Inc.$23.68 ↑ +0.00 (+0.00%) Trading Up from the previous close of $23.68, $0.55 below the day’s high of $24.23
- YTD change
- +3.05%
- vs 20-day SMA
- -9.36%
- vs 200-day SMA
- -6.19%
Price ranges
Price & Performance
-0.21 (-0.90%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $253,440.00
- PRPO is up 3% since the beginning of the year
- PRPO is up 33% over the past 12 months
- PRPO is down 14% over the past 1 month
- 4% of all PRPO investors are betting against PRPO
PRPO reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is +33.1%.
- Previous minute
- +$0.00
- Last hour
- -$0.12
- Last 5 days
- -9.84%
- vs 8-day SMA
- -4.88%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. It operates through the following business divisions: Pathology Services and Products. The Pathology Services division provides specialized cancer diagnostic testing services to physicians, hospitals, and laboratories. The Products divisions develops and commercializes proprietary assays designed for use by clinical laboratories. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.